1. Home
  2. TMDX vs MQ Comparison

TMDX vs MQ Comparison

Compare TMDX & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • MQ
  • Stock Information
  • Founded
  • TMDX 1998
  • MQ 2010
  • Country
  • TMDX United States
  • MQ United States
  • Employees
  • TMDX N/A
  • MQ N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MQ Computer Software: Prepackaged Software
  • Sector
  • TMDX Health Care
  • MQ Technology
  • Exchange
  • TMDX Nasdaq
  • MQ Nasdaq
  • Market Cap
  • TMDX 2.3B
  • MQ 1.9B
  • IPO Year
  • TMDX 2019
  • MQ 2021
  • Fundamental
  • Price
  • TMDX $127.12
  • MQ $5.38
  • Analyst Decision
  • TMDX Buy
  • MQ Hold
  • Analyst Count
  • TMDX 10
  • MQ 13
  • Target Price
  • TMDX $122.89
  • MQ $4.95
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • MQ 10.3M
  • Earning Date
  • TMDX 05-08-2025
  • MQ 05-07-2025
  • Dividend Yield
  • TMDX N/A
  • MQ N/A
  • EPS Growth
  • TMDX N/A
  • MQ N/A
  • EPS
  • TMDX 1.41
  • MQ 0.11
  • Revenue
  • TMDX $488,227,000.00
  • MQ $528,100,000.00
  • Revenue This Year
  • TMDX $32.58
  • MQ $19.36
  • Revenue Next Year
  • TMDX $21.65
  • MQ $22.24
  • P/E Ratio
  • TMDX $90.23
  • MQ $50.26
  • Revenue Growth
  • TMDX 64.43
  • MQ N/A
  • 52 Week Low
  • TMDX $55.00
  • MQ $3.37
  • 52 Week High
  • TMDX $177.37
  • MQ $6.00
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 76.52
  • MQ 75.61
  • Support Level
  • TMDX $118.79
  • MQ $5.01
  • Resistance Level
  • TMDX $130.48
  • MQ $5.33
  • Average True Range (ATR)
  • TMDX 4.49
  • MQ 0.17
  • MACD
  • TMDX -0.15
  • MQ 0.03
  • Stochastic Oscillator
  • TMDX 83.53
  • MQ 96.61

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Share on Social Networks: